van der Most R G, Sette A, Oseroff C, Alexander J, Murali-Krishna K, Lau L L, Southwood S, Sidney J, Chesnut R W, Matloubian M, Ahmed R
Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
J Immunol. 1996 Dec 15;157(12):5543-54.
The cytotoxic T cell response against lymphocytic choriomeningitis virus (LCMV) in BALB/c (H-2d) mice is predominantly directed against a single immunodominant Ld-restricted epitope in the viral nucleoprotein (NP118-126). Here we report that the immunodominance of this peptide can be in part attributed to its very high affinity for Ld class I molecules. By employing motif searches and sensitive MHC class I binding assays, we also identified 5 Kd-binding peptides in the viral nucleoprotein and glycoprotein among 16 Kd motif-fitting peptides. The nucleoprotein and glycoprotein sequences also contained 18 Dd motif-fitting peptides, three of which bound Dd with weak affinity. Two of the Kd-binding peptides, residues 99-108 and residues 283-291 from the viral glycoprotein, are subdominant epitopes. Although these peptides did not sensitize target cells for direct ex vivo killing by primary antiviral CTL, secondary responses against these peptides were readily detected in BALB/c mice after acute LCMV infection. BALB/c mice that had cleared a long-term LCMV infection showed more sustained CTL responses against these subdominant epitopes, suggesting that subdominant responses might play a role in clearance of chronic infections. One of the subdominant epitopes, GP283-291, conferred partial protection against persistent viral infection after peptide vaccination.
BALB/c(H-2d)小鼠针对淋巴细胞性脉络丛脑膜炎病毒(LCMV)的细胞毒性T细胞反应主要针对病毒核蛋白(NP118-126)中单个免疫显性的Ld限制性表位。我们在此报告,该肽的免疫显性部分可归因于其对I类Ld分子的极高亲和力。通过基序搜索和灵敏的MHC I类结合试验,我们还在16个符合Kd基序的肽中鉴定出病毒核蛋白和糖蛋白中的5个Kd结合肽。核蛋白和糖蛋白序列中还包含18个符合Dd基序的肽,其中3个与Dd的结合亲和力较弱。两个Kd结合肽,即病毒糖蛋白的99-108位残基和283-291位残基,是亚显性表位。尽管这些肽不能使靶细胞对原代抗病毒CTL的直接体外杀伤敏感,但在急性LCMV感染后的BALB/c小鼠中很容易检测到针对这些肽的二次反应。清除长期LCMV感染的BALB/c小鼠对这些亚显性表位表现出更持久的CTL反应,这表明亚显性反应可能在慢性感染的清除中起作用。其中一个亚显性表位GP283-291在肽疫苗接种后对持续性病毒感染提供了部分保护。